Skip to content

Evaluation of Rheumatoid Arthritis Disease Education Literature

Evaluation of Rheumatoid Arthritis Disease Education Literature: The ERADEL Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03336684
Acronym
ERADEL
Enrollment
376
Registered
2017-11-08
Start date
2017-12-18
Completion date
2019-06-30
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

Patient education, Rheumatoid arthritis, Knowledge, Attitudes, Practice

Brief summary

Rheumatoid arthritis is an inflammatory disease that results in joint inflammation, pain and swelling. It may progress to advance stages that render patients unable to carry out their daily activities. It also results in joints deformity and is a leading cause of disability globally. Patient education plays an important role in the management of disease. Adequate patient knowledge and awareness about disease may help in incorporating the ailment in daily life. The purpose of this study is to evaluate the benefit of a disease education literature in Urdu language and with culturally relevant illustration for rheumatoid arthritis patients.

Interventions

BEHAVIORALPatient education

Rheumatoid arthritis patients will be provided with disease education literature

Sponsors

Universiti Sains Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Masking description

The investigator will be blinded from randomization and recruitment process.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Out-patients with established diagnosis of rheumatoid arthritis over 3 months. 2. Participants who are willing to participate in the study.

Exclusion criteria

1. Patients with no rheumatoid arthritis. 2. Patients currently undergoing surgery or had previous history of surgery. 3. Patients who are not willing to participate. 4. In-patients.

Design outcomes

Primary

MeasureTime frameDescription
Patient knowledge about rheumatoid arthritis3 monthsMeasurement of patient's knowledge and awareness about rheumatoid arthritis using The 13-item Rheumatoid Arthritis Knowledge Assessment Scale (RAKAS-13) before and after the intervention. The RAKAS-13 is a psychometric tool consisting of 13 multiple choice questions related to rheumatoid arthritis disease knowledge. All questions have 1 point for Right answer and zero (0) points for Wrong answer. The scoring criteria are as follows: Excellent knowledge More than 75% correct answers = Above 11 points Adequate knowledge More than 50% or equal to 75% correct answers = 8 - 10 points Low knowledge More than 30% or equal to 50% correct answers = 5 - 7 points Poor knowledge Less than 30% correct answers = 4 points or less.

Secondary

MeasureTime frameDescription
Patient satisfaction3 monthsPatient satisfaction with be documented after the educational intervention using a patient satisfaction feedback form. It contains 10 questions related to general satisfaction from the intervention

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026